Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Academy of Pediatrics. (2000). Pneumococcal infections. In L. K. Pickering (Ed.), 2000 red book: Report of the Committee on Infectious Diseases (p. 460). Elk Grove Village, IL: Author.
American Thoracic Society. (2001). Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med, 163, 1730–1754.
Amsden, G. W. (1999). Pneumococcal macrolide resistance—myth or reality? J Antimicrob Chemother, 44, 1–6.
Araj, G. F, Bey, H. A., Itani, L. Y., & Kanj, S. S. (1999). Drug-resistant Streptococcus pneumoniae in the Lebanon: Implications for presumptive therapy. Int J Antimicrob Agents, 12, 349–354.
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A., Koornhof, H., Hayden-Smith, S., & Reid, R. (1976). Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians, 89, 184–189.
Austrian, R., & Gold, J. (1964). Pneumococcal bacteremia with especial [sic] reference to bacteremic pneumococcal pneumonia. Ann Intern Med, 60, 759–776.
Barker, J. H., Musher, D. M., Silberman, R., Phan, H. M., & Watson, D. A. (1999). Genetic relatedness among nontypeable pneumococci implicated in sporadic cases of conjunctivitis. J Clin Microbiol, 37, 4039–4041.
Barrett, N., Reingold, A., Gershman, K., McCombs, K., Harrison, L., Johnson, S., Hibbs, J., Cassidy, M., Cieslak, P., Craig, A., Jorgensen, J., Feikin, D., Whitney, C., & Chuang, I. (2002). Assessment of Antibiotic-Resistant Streptococcus pneumoniae susceptibility testing practices for Streptococcus pneumoniae—United States, February 2000. Morb Mortal Wkly Rep, 51, 392–394.
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Jr., Musher, D. M, & Fine, M. J. (2000). Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis, 31, 347–382.
Bell, J.M., Turnidge, J.D., Jones, R.N., & The Sentry Regional Participants Group. (2002). Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: Report from the SENTRY antimicrobial surveillance program, (1998–1999) including an in vitro evaluation of BMS284756. Int J Antimicrob Agents, 19, 125–132.
Benbachir, M., Benredjeb, S., Boye, C.S., Dosso, M., Belabbes, H., Kamoun, A., Kaire, O., & Elmdaghri, N. (2001). Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother, 45, 627–629.
Black, S., Shinefield, H., Fireman, B., Ray, P., Hansen, J.R., Elvin, L., Ensor, K.M., Hackell, J., Siber, G., Malinoski, F., Madore, D., Chang, I., Kolberger, R., Watson, W., & Austrian, R. (2000). Efficacy, safety and immunogenicity of heptavalent conjugate pneumococcal vaccine in children. Northern California Kaiser Permanente Study Center Group. Pediatr Infect Dis J, 19, 187–195.
Breiman, R. F., Keller, D. W., Phelan, M., Sniadack, H., Stephens, D. S., Rimland, D., Farley, M. M., Schuchat, A., & Reingold, A. L. (2000). Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med, 160, 2633–2638.
Brenwald, N., Gill, M., & Wise, R. (1998). Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother, 42, 2032–2035.
British Thoracic Society Standards of Care Committee. (2001). BTS guidelines for the management of community-acquired pneumonia in adults. Thorax, 56, iv1–iv64.
Brown, D. F. J. (1994). Developments in antimicrobial susceptibility testing. Rev Med Microbiol, 5, 65–75.
Brueggemann, A. B., Coffman, S. L., Rhomberg, P., Huynh, H., Almer, L., Nilius, A., Flamm, R., & Doern, G. V (2002). Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994–1995. Antimicrob Agents Chemother, 46, 680–688.
Buckingham, S. C., Brown, S. P., & Joaquin, V. H. (1998). Breakthrough bacteremia and meningitis during treatment parenterally with cephalosporins for pneumococcal pneumonia. J Pediatr, 132, 174–176.
Butler, J. C., Breiman, R. F., Campbell, J. F., Lipman, H. B., Broome, C. V., & Facklam, R. R. (1993). Polysaccharide pneumococcal vaccine efficacy: An evaluation of current recommendations. JAMA, 270, 1826–1831.
Centers for Disease Control and Prevention. (1997). Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep, 46, 1–24.
Centers for Disease Control and Prevention. (2000). Prevention of pneumococcal disease among infants and young children: Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep, 49(No. RR-9), 1–35.
Charpentier, E., & Tuomanen, E. (2000). Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect, 2, 1855–1864.
Chen, D.K., McGeer, A., de Azavedo, J.C., & Low, D.E. (1999). Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med, 341, 233–239.
Choi, E., & Lee, H. (1998). Clincial outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis, 26, 1346–1354.
Clavo-Sanchez, A. J., Giron-Gonzalez, J. A., Lopez-Prieto, D., Canueto-Quintero, J., Sanchez-Porto, A., Vergara-Campos, A., Marin-Casanova, P., & Cordoba-Dona, J. A. (1997). Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study. Clin Infect Dis, 24, 1052–1059.
Cybulska, J., Jeljaszewicz, J., Lund, E., & Munksgaard, A. (1970). Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics. Chemotherapy, 15, 304–316.
Dagan, R., Givon-Lavi, N., Zamir, O., Sikuler-Coheh, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002). Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis, 185, 927–936.
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996). Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate vaccine. J Infect Dis, 174, 1271–1278.
Dagan, R., Muallem, M., Melamed, R., Leroy, O., & Yagupsky, P. (1997). Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J, 16, 1060–1064.
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C, Kibsey, P., Fleming, C., & Low, D. E. (2002). Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med, 346, 747–750.
Deeks, S. L., Palacio, R., Ruinsky, R., et al. (1999). Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics, 103, 409–413.
di Fabio, J. L., Castaneda, E., Agudelo, C. I., de la Hoz, F., Hortal, M., Camou, T., Echaniz-Aviles, G., Noemi, M., Barajas, C., Heitmann, L, Hormazabal, J. C., Brandileone, M. C., Dias Vieira, V. S., Regueira, M., Ruvinski, R., Corso, A., Lovgren, M., Talbot, J. A., & de Quadros, C. (2001). Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. PAHO Sireva-Vigia Study Group. Pan American Health Organization. Pediatr Infect Dis J, 20, 959–967.
Doern, G. V. (1995). Interpretive criteria for in vitro antimicrobial susceptibility testing. Rev Med Microbiol, 6, 126–136.
Doern, G. V., Brueggemann, A. B., Pfaller, M. A., & Jones, R. N. (1999). Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: A report from the College of American Pathologists Microbiology Proficiency Survey Program. Arch Path Lab Med, 123, 285–289.
Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000, including a comparison of resistance rates since 1994–1995. Antimicrob Agents Chemother, 45, 1721–1729.
Dowell, S. F., Butler, J. C., Giebink, S., Jacobs, M. R., Jernigan, D., Musher, D., Rakowsky, A., Schwartz, B., & Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. (1999a). Acute otitis media: Management and surveillance in an era of pneumococcal resistance—A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J, 18, 1–9.
Dowell, S. F., Marcy, S. M., Phillips, W. R., Gerber, M. A., & Schwartz, B. (1998). Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics, 101, 163–165.
Dowell, S. F., Smith, T., Leversedge, K., & Snitzer, J. (1999b). Pneumonia treatment failure associated with highly-resistant pneumococci. Clin Infect Dis, 29, 462–463.
Ekdahl, K., Ahlinder, I., Hansson, H. B., Melander, E., Molstad, S., Soderstrom, M., & Persson, K. (1997). Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis, 25, 1113–1117.
Ertugrul, N., Rodriguez-Barradas, M. C., Musher, D. M., Ryan, M. A. K., Agin, C. S., Murphy, S. J., Shayegani, M., & Watson, D. A. (1997). BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis, 176, 1401–1405.
Evans, W., & Hansman, D. (1963). Tetracycline-resistant pneumococcus. Lancet, i, 451.
Farr, B. M., Johnston, B. L., Cobb, D. K., Fisch, M. J., Germanson, T. P., Adal, K. A., & Anglim, A. M. (1995). Preventing pneumococcal bacteremia in patients at risk: Results of a matched case-control study. Arch Intern Med, 155, 2336–2340.
Fedson, D. S. (1998). Pneumococcal vaccination in the United States and 20 other developed countries. Clin Infect Dis, 26, 1117–1123.
Feikin, D. R., Schuchat, A., Kolczak, M., Barrett, N. L., Harrison, L. H., Lefkowitz, L., McGeer, A., Farley, M. M., Vugia, D. J., Lexau, C., Stefonek, K. R., Patterson, J. E., & Jorgensen, J. H. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health, 90, 223–229.
Filipe, S. R., Severina, E., & Tomasz, A. (2002). The murMN operon: A functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae. Proc Natl Acad Sci USA, 99, 1550–1555.
Friedland, I. R. (1995). Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J, 14, 885–890.
Friedland, I. R., & Klugman, K. P. (1992). Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child, 146, 920–923.
Frisch, A., Price, A., & Myers, G. (1943). Type VIII pneumococcus: Development of sulfadiazine resistance, transmission by cross infection, and persistence in carriers. Ann Intern Med, 18, 271–278.
Gaillat, J., Zmirou, D., Mallaret, M. R., Rouhan, D., Bru, J. P., Stahl, J. P., Delormas, P., & Micoud, M. (1985). Essai clinique du vaccin antipneumococcique chez des personnes ágées vivant en institution. Rev Epidémiol Santé Publique, 33, 437–444.
Georgopoulos, A., Buxbaum, A., Straschil, U., & Graninger, W. (1998). Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994–96. Scand J Infect Dis, 30, 345–349.
Geslin, P., Fremaux, A., Spicq, C., Sissia, G., & Georges, S. (1997). Use of a DNA probe test for identification of Streptococcus pneumoniae nontypable strains. Adv Exp Med Biol, 418, 383–385.
Ghaffar, F., Friedland, I.R., & McCracken, G. H., Jr. (1999). Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Ped Infect Dis J, 18, 638–646.
Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001). Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods. Ann Intern Med, 134, 479–86.
Gonzales, R., Steiner, J. F., & Sande, M. A. (1997). Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA, 278, 901–904.
Gray, B., Converse, 3rd, G., & Dillon, H., Jr. (1980). Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life. J Infect Dis, 142, 923–933.
Grebe, T., Paik, J., & Hakenbeck, R. (1997). A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J Bacterial, 179, 3342–3349.
Gur, D., Guciz, B., Hascelik, G., Esel, D., Sumerkan, B., Over, U., Soyletir, G., Ongen, B., Kaygusuz, A., & Toreci, K. (2001). Streptococcus pneumoniae penicillin resistance in Turkey. J Chemother, 13, 541–545.
Hansman, D., & Bullen, M. (1967). A resistant pneumococcus. Lancet, ii, 264–265.
Hausdorff, W. P., Bryant, J., Paradiso, P. R., & Siber, G. R. (2000). Which pneumococcal serogroups cause the most invasive disease: Implication for conjugate vaccine formulation and use, part 1. Clin Infect Dis, 30, 100–121.
Heffelfinger, J. D., Dowell, S. F., Jorgensen, J. H., Klugman, K. P., Mabry, L. R., Musher, D. M., Plouffe, J. F., Rakowsky, A., Schuchat, A., Whitney, C. G., & Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. (2000). Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med, 160, 1399–1408.
Hendley, J. O., Sande, M. A., Stewart, P. M., & Gwaltney, J. M. J. (1975). Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis, 132, 55–61.
Hermans, P. W., Sluijter, M., Elzenaar, K., van Veen, A., Schonkeren, J. J., Nooren, F M., van Leeuwen, W. J., de Neeling, A. J., van Klingeren, B., Verbrugh, H. A., & de Groot, R. (1997). Penicillin-resistant Streptococcus pneumoniae in the Netherlands: Results of a 1-year molecular epidemiologic survey. J Infect Dis, 175, 1413–1422.
Ho, P. L., Tse, W. S., Tsang, K. W., Kwok, T. K., Ng, T. K., Cheng, V. C., & Chan, R. M. (2001a). Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study. Clin Infect Dis, 32, 701–707.
Ho, P. L., Yam, W. C., Cheung, T. K., Ng, W. W., Que, T. L., Tsang, D. N., Ng, T. K., & Seto, W. H. (2001b). Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. Emerg Infect Dis, 7, 906–908.
Ho, P. L., Yung, R. W., Tsang, D. N., Que, T. L., Ho, M., Seto, W. H., Ng, T. K., Yam, W. C., & Ng, W. W. (2001c). Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: Results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother, 48, 659–665.
Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel-Delvallez, M., & Jones, R. N. (2001). Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis, 32, S81–93.
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995). The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med, 333, 481–86.
Honkanen, P. O., Keistinen, T, Miettinen, L., Herva, E., Sankilampi, U, Laara, E., Leinonen, M., Kivela, S. L., & Makela, P. H. (1999). Incremental effectiveness of pneumococcal vaccine on simultaneously-administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine, 17, 2493–2500.
Huebner, R. E., Wasas, A. D., & Klugman, K. P. (2000). Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991–1998. Int J Infect Dis, 4, 214–218.
Hyde, T. B., Gay, K., Stephens, D. S., Vugia, D. J., Pass, M., Johnson, S., Barrett, N. L., Schaffner, W., Cieslak, P. R., Maupin, P. S., Zell, E. R., Jorgensen, J. H., Facklam, R. R., Whitney, C. G., & Active Bacterial Core Surveillance/Emerging Infections Program Network. (2001). Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA, 286, 1857–1862.
Jacobs, M., Koornhoof, H., Robins-Browne, R., Stevenson, C., Vermaak, Z., Frieman, I., Miller, G., Witcomb, M., Isaacson, M., Ward, J., & Austrian, R. (1978). Emergence of multiply resistant pneumococci. N Engl J Med, 299, 735–740.
Kamme, C., Ekdahl, K., & Molstad, S. (1999). Penicillin-resistant pneumococci in southern Sweden, 1993–1997. Microb Drug Res, 5, 31–36.
Kaufman, P. (1947). Pneumonia in old age: Active immunization against pneumonia with pneumococcus polysaccharide: Results of a six year study. Arch Intern Med, 79, 518–531.
Kelley, M., Weber, D., Gilligan, P., & Cohen, M. (2000). Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis, 31, 1008–1011.
Kellner, J. D. (2001). Drug-resistant Streptococcus pneumoniae infections: Clinical importance, drug treatment, and prevention. Semin Respir Infect, 16, 186–195.
Kislak, J. (1967). Type 6 pneumococcus resistant to erythromycin and lincomycin. N Engl J Med, 276, 852.
Koeth, L. M., Jacobs, M. R., Bajaksouzian, S., Zilles, A., Lin, G., & Appelbaum, P.C. (2002). Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999–2000. Int J Antimicrob Agents, 19, 33–37.
Koivula, I., Stén, M., Leinonen, M., & Mä;kelä;, P. H. (1997). Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind population-based trial. Am J Med, 103, 281–290.
Konradsen, H. B., & Kaltoft, M. S. (2002). Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol, 9, 358–365.
Koornhof, H. J., Keddy, K., & McGee, L. (2001). Clonal expansion of bacterial pathogens across the world. J Travel Med, 8, 29–40.
Koskela, M., Leinonen, M., Hä;ivä;, V.-M., Timonen, M., & Mä;kelä;, P. H. (1986). First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis J, 5, 45–50.
Kristiansen, B. E., Sandnes, R. A., Mortensen, L., Tveten, Y., & Vorland, L. (2001). The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low. Clin Microbiol Infect, 7, 682–687.
Kyaw, M. H., Clarke, S., Jones, I. G., & Campbell, H. (2002). Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect, 128, 139–147.
Lagrou, K., Peetermans, W., Verhaegen, J., Lierde, S., Verbist, L., & Eldere, J. (1999). Macrolide resistance in Belgian Streptococcus pneumoniae. J Antimicrob Chemother, 44, 119–121.
Levine, O. S., Farley, M., Harrison, L. H., Lefkowitz, L., McGeer, A., & Schwartz, B. (1999). Risk factors for invasive pneumococcal disease in children: A population-based case-control study in North America. Pediatrics, 103, E28.
Lipsitch, M. (2001). Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis, 32, 1044–1054.
Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., & Hyland, R. H. (2000). Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis, 31, 383–421.
Maraki, S., Christidou, A., & Tselentis, Y. (2001). Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolates from Crete, Greece. Int J Antimicrob Agents, 17, 465–69.
Marchese, A., Mannelli, S., Tonoli, E., Gorlero, F., Toni, M., & Schito, G. C. (2001). Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulatingin Italy: Results of the Italian Epidemiological Observatory Survey (1997–1999). Microb Drug Resist, 7, 277–287.
Marchese, A., Tonoli, E., Debbia, E. A., & Schito, G.C. (1999). Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother, 44, 461–464.
Marston, B. J., Plouffe, J. F., File, T. M., Jr., Hackman, B. A., Salstrom, S. J., Lipman, H. B., Kolczak, M. S., & Breiman, R. F. (1997). Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med, 157, 1709–1718.
Marton, A., & Meszner, Z. (1999). Epidemiological studies on drug resistance in Streptococcus pneumoniae in Hungary: An update for the 1990s. Microb Drug Res, 5, 201–205.
Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999). Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococccal conjugate vaccine. J Infect Dis, 180, 1171–1176.
McCaig, L. F., Besser, R. E., & Hughes, J. M. (2002). Trends in antimicrobial prescribing rates for children and adolescents. JAMA, 287, 3096–3102.
McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefevre, J. C., Tomasz, A., & Klugman, K. P. (2001). Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol, 39, 2565–2571.
Melo-Cristino, J., Fernandes, M. L., Serrano, N., & The Portuguese Surveillance Group for the Study of Bacterial Respiratory Pathogens. (2001). A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal. Microb Drug Res, 7, 33–38.
Mokaddas, E. M., Wilson, S., & Sanyal, S. C. (2001). Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait. J Chemother, 13, 154–160.
Mulholland, K. (1999). Strategies for the control of pneumococcal diseases. Vaccine, 17, S79–S84.
National Advisory Committee on Immunization. (2002). Pneumococcal vaccine. In Canadian immunization guide (6th ed., pp. 177–184). Ottawa: Canadian Medical Association.
NCCLS. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard (5th ed.). In NCCLS document M7-A5 (Vol. 20). Wayne, PA: Author.
NCCLS. (2002). Performance standards for antimicrobial susceptibility testing: Twelfth informational supplement. In NCCLS document M100-S12 (Vol. 22). Wayne, PA: Author.
Normark, B., Novak, R., Örtqvist, Å, Källenius, G., Tuomanen, E., & Normark, S. (2001). Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis, 32, 552–558.
Novak, R., Henriques, B., Charpentier, E., Normark, S., & Tuomanen, E. (1999). Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature, 399, 590–593.
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., Breiman, R. F., & Active Bacterial Core Surveillance Team. (2000). Cigarette smoking and invasive pneumococcal disease. N Engl J Med, 342, 681–689.
Nyquist, A. C., Gonzales, R., Steiner, J. F, & Sande, M. A. (1998). Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA, 279, 875–877.
Obaro, S. K., Adegbola, R. A., Banya, W. A. S., & Greenwood, B. M. (1996). Carriage of pneumococci after pneumococcal vaccination. Lancet, 348, 271–272.
Obaro, S. K., Adegbola, R. A., Chang, I., Banya, W. A. S., Jaffar, S., McAdam, K. W. J. P., & Greenwood, B. M. (2000). Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis J, 19, 463–469.
Örtqvist, Å., Hedlund, J., Burman, L. Å., Elbel, E., Hofer, M., Leinonen, M., Lindblad, I., Sundelof, B., & Kalin, M. (1998). Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-age and elderly people. Lancet, 351, 399–03.
Oteo, J., Alos, J. I., & Gomez-Garces, J. L. (2001). Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: A multicentre surveillance study. J Antimicrob Chemother, 47, 215–218.
Overweg, K., Hermans, P. W., Trzcinski, K., Sluijter, M., de Groot, R., & Hryniewicz, W. (1999). Multidrug-resistant Streptococcus pneumoniae in Poland: Identification of emerging clones. J Clin Microbiol, 37, 1739–1745.
Pallares, R., Gudiol, F., Linares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. (1987). Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med, 317, 18–22.
Pallares, R., Linares, J., Vadillo, M., et al. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med, 333, 474–480.
Pana, M., Ungureanu, V., Mihalcu, F, Vereanu, A., & Stanescu, C. (1997). Study of resistant pneumococci in Romania between 1973–1995. Adv Exp Med Biol, 418, 471–473.
Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., & Spanish Surveillance Group for Respiratory Pathogens. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998–1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother, 45, 3334–3340.
Pneumococcal Molecular Epidemiology Network, 2001. (2002, August 6). http://pneumo.com/physician/html/pmen/history/history.asp
Robinson, K. A., Baughman, W., Rothrock, G., Barrett, N. L., Pass, M., Lexau, C., Damaske, B., Stefonek, K., Barnes, B., Patterson, J., Zell, E. R., Schuchat, A., Whitney, C. G., & Active Bacterial Core Surveillance/Emerging Infections Program Network. (2001). Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era. JAMA, 285, 1729–1735.
Sahm, D. F., Jones, M. E., Hickey, M. L., Diakun, D. R., Mani, S. V., & Thornsberry, C. (2000). Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998. J Antimicrob Chemother, 45, 457–466.
Sankilampi, U., Herva, E., Haikala, R., Liimatainen, O., Renkonen, O. V., & Leinonen, M. (1997). Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect, 118, 7–15.
Schmitz, F.-J., Verhoef, J., Milatovic, D., & Fluit, A. C. (2001). Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole. Eur J Clin Microbiol Infect Dis, 20, 827–829.
Schrag, S. J., Beall, B., & Dowell, S. F. (2000). Limiting the spread of resistant pneumococci: Biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev, 13, 588–601.
Schrag, S. J., Pena, C., Fernandez, J., Sanchez, J., Gomez, V, Perez, E., Feris, J. M., & Besser, R. E. (2001). Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: A randomized trial. JAMA, 286, 49–56.
Schrag, S. J., Zell, E. R., Schuchat, A., & Whitney, C. G. (2002). Sentinel surveillance: A reliable way to track antibiotic resistance in communities? Emerg Infect Dis, 8, 496–502.
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997). Bacterial meningitis in the United States in 1995. N Engl J Med, 337, 970–976.
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991). The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med, 325, 1453–1460.
Shayegani, M., Malmberg Parsons, L., Gibbons Jr., W. E., & Campbell, D. (1982). Characterization of nontypable Streptococcus pneumoniae-like organisms from outbreaks of conjunctivitis. J Clin Microbiol, 16, 8–14.
Shibl, A. M., Al Rasheed, A. M., Elbashier, A. M., & Osoba, A. O. (2000). Penicillin-resistant and-intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother, 12, 134–137.
Shinefield, H. R., & Black, S. (2000). Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J, 19, 394–397.
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., & Shepard, D. S. (1986). Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med, 315, 1318–1327.
Sims, R. V, Steinmann, W. C., McConville, J. H., King, L. R., Zwick, W. C., & Schwartz, J. S. (1988). The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med, 108, 653–657.
Smit, P., Oberholzer, D., Hayden-Smith, S., Koornhof, H. J., & Hilleman, M. R. (1977). Protective efficacy of pneumococcal polysaccharide vaccines. JAMA, 238, 2613–2616.
Song, J. H., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C. H., Lalitha, M. K., Thomas, K., Perera, J., Yee, T. T., Jamal, E, Warsa, U. C., Vinh, B.X., Jacobs, M.R., Appelbaum, P.C., & Pai, C.H. (1999). Spread of drug-resistant Streptococcus pneumoniae in Asiancountries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis, 28, 1206–1211.
Tait-Kamradt, A., Davies, T., Appelbaum, P., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000). Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother, 44, 3395–3401.
Thornsberry, C., Sahm, D. F., Kelly, L. J., Critchley, I. A., Jones, M. E., Evangelista, A. T., & Karlowsky, J.A. (2002). Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000. Clin Infect Dis, 34, S4–S16.
Tillotson, G. S., & Watson, S. J. (2001). Antimicrobial resistance mechanisms: What’s hot and what’s not in respiratory pathogens. Semin Respir Infect, 16, 155–168.
Turett, G. S., Blum, S., Fazal, B. A., Justman, J. E., & Telzak, E. E. (1999). Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis, 29, 321–327.
U.S. Preventive Services Task Force. (1996). Guide to clinical preventive services (2nded.). Baltimore: Williams & Wilkins.
Verhaegen, J., Van De Ven, J., Verbiest, N., Van Eldere, J., & Verbist, L. (2000). Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium—update 1994–98). Clin Microbiol Infect, 6, 308–315.
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., Jorgensen, J. H., & Schuchat, A. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med, 343, 1917–1924.
Widdowson, C. A., & Klugman, K. P. (1998). Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis, 4, 277–281.
Wortmann, G., & Bennett, S.(1999). Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae. Clin Infect Dis, 29, 1599–1600.
Yoshimine, H., Oishi, K., Mubiru, F., Nalwoga, H., Takahashi, H., Amano, H., Ombasi, P., Watanabe, K., Joloba, M., Aisu, T., Ahmed, K., Shimada, M., Mugerwa, R., & Nagatake, T. (2001). Community-acquired pneumonia in Ugandan adults: Short-term parenteral ampicillin therapy for bacterial pneumonia. Am J Trap Med Hyg, 64, 172–177.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Whitney, C.G., Glass, N.E. (2004). Antibiotic-ressistant Streptococcus pneumoniae: Implications for Management in the 21st Century. In: Fong, I.W., Drlica, K. (eds) Reemergence of Established Pathogens in the 21st Century. Emerging Infectious Diseases of the 21st Century, vol 2. Springer, Boston, MA. https://doi.org/10.1007/0-306-48411-0_3
Download citation
DOI: https://doi.org/10.1007/0-306-48411-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47500-9
Online ISBN: 978-0-306-48411-7
eBook Packages: Springer Book Archive